In 2020 we introduced the “5 Questions With…” in an effort to spotlight individuals from across the BioHealth Capital Region and beyond. Since then, we have highlighted a plethora of professionals at all levels, from early career to the C-suite, from scientists to business developers to managers and directors, and all facets in between. To celebrate, we’d like to highlight the Top 5 most viewed interviews from 2021.
“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little about themselves, their work, and maybe something completely unrelated. This week we welcome Ronald T. Piervincenzi, Ph.D., Chief Executive Officer, United States Pharmacopeia.
United States Pharmacopeia acquires Pharmatech Associates, Inc. to expand services that help ensure the quality of medicines
United States Pharmacopeia (USP), an independent, scientific nonprofit organization, is pleased to announce the acquisition of Pharmatech Associates, Inc. By adding Pharmatech Associates expertise, USP further advances its more than 200-year mission to help ensure access to quality medicines by extending services that assist manufacturers to meet global quality standards across the drug and product lifecycle.